<DOC>
	<DOCNO>NCT00305240</DOCNO>
	<brief_summary>The purpose study determine usefulness microvolt T wave alternans ( MTWA ) test patient heart attack decrease pump ability low chamber heart . MTWA test non-invasive test use detect likelihood develop abnormally fast rhythms low chamber heart . The objective study prove patient negative MTWA test , less likely develop abnormally fast dangerous rhythm low chamber heart . The result study help doctor determine patient would benefit Implantable Cardioverter Defibrillator ( ICD ) implant .</brief_summary>
	<brief_title>MASTER I - Microvolt T Wave Alternans Testing Risk Stratification Post MI Patients</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Patients indicate ICD history heart attack LVEF &lt; = 0.30 measure radionuclide study , angiography quantitative echocardiography within 3 month prior enrollment Patients electrocardiographically document sustained ventricular tachycardia , ventricular fibrillation prior cardiac arrest ( Class I indication ) Patients undergone electrophysiologic study ventricular stimulation MTWA test within 1 year prior enrollment Patients medical condition preclude test require Investigational Plan limit study participation Patients unable complete MTWA testing requirement due current atrial fibrillation flutter Patients unable exercise alternative modality ( pace pharmacological stress ) use MTWA test available Patients experience MI within 1 month prior enrollment Patients advance cerebrovascular disease per physician 's assessment Patients classify NYHA Class IV time enrollment Patients undergone cardiac revascularization within 3 month prior enrollment schedule cardiac revascularization time enrollment Patients life expectancy le 1 year Patients prior ICD Patients unable complete followup visit study center Patients enrol intend participate another clinical study would compete study objective ( assessment responsibility Clinical Trial Leader guidance Executive Committee )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Microvolt T Wave Alternans Test</keyword>
	<keyword>Implantable Cardioverter Defibrillator ( ICD )</keyword>
	<keyword>Ventricular Arrythmias</keyword>
</DOC>